1-20 of 29
Matthew Frigault
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outpatient (OP) use of lisocabtagene maraleucel (liso-cel) in patients (Pts) with relapsed or refractory (R/R) large B-cell lymphoma (LBCL): Real-world data from the CIBMTR registry

Free
Krish Patel, Matthew Lunning, Konstantinos Sdrimas, Minoo Battiwalla, Uttam Rao, Yi Lin, Sami Ibrahimi, Jennifer L. Crombie, Sairah Ahmed, Iris Isufi, Matthew Frigault, David Bernasconi, Debasmita Roy, Marcelo Pasquini, Bradley D. Hunter
Journal: Blood
Blood (2025) 146 (Supplement 1): 5482.
https://doi.org/10.1182/blood-2025-5482
Published: 2025
Journal Articles

A phase 1b/2a study of CTO1681 for the prevention of cytokine release syndrome in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy

Free
Jordan Gauthier, Matthew Frigault, Arthur Bertolino, Michael Howell, Teresa Whalen
Journal: Blood
Blood (2025) 146 (Supplement 1): 5955.
https://doi.org/10.1182/blood-2025-5955
Published: 2025
Journal Articles

Single-cell transcriptomics reveal mechanisms of efficacy and toxicity in anti-BCMA CAR-T cell therapies for multiple myeloma

Free
Xiaomeng Sun, Charlotte Graham, Aiyana Parker, Maria Dolaher, Kevin Lindell, Deshea L Harris, Won-Ho Lee, Kiana Graham, Hannah Nolan, Viktoria Blumenberg, David Bozym, Diana Cirstea, Andrew Branagan, Andrew Yee, Noopur Raje, Mark Leick, Matthew Frigault, Kathleen ME Gallagher, Nicholas Haradhvala, Gad Getz, Marcela Maus
Journal: Blood
Blood (2025) 146 (Supplement 1): 503.
https://doi.org/10.1182/blood-2025-503
Published: 2025
Journal Articles

Mechanistic basis of the acute safety profile of rese-cel, an autologous CD19-CAR T, in patients with autoimmune disease treated in four ongoing phase 1/2 clinical trials

Free
Daniel Nunez, Jenell Volkov, Dan Thompson, Fatemeh Hadi Nezhad, Domenick Braccia, Jason Stadanlick, Thomas Fumanak, Mallorie Werner, Zachary Vorndran, Larissa Ishikawa, Alexandra Ellis, Steve Flanagan, Jazmean Williams, Justin Cicarelli, Danielle Kobulsky, Quynh Lam, Courtney Little, Yvonne White, Saira Sheikh, Vimal Derebail, Natalie Grover, Gaurav Gulati, Mehrdad Abedi, Meghan Sise, Matthew Frigault, Christopher Palma, Patrick Reagan, Cuoghi Edens, Satyajit Kosuri, Caitlin Elgarten, Jon Burnham, Christina Ulane, Ran Reshef, Tahseen Mozaffar, Elie Naddaf, Nizar Chahin, Erin Wilfong, Dinesh Khanna, Monalisa Ghosh, Ankoor Shah, Jonathan Hogan, Rebecca Estremera, Raj Tummala, David Chang, Gwendolyn Binder, Samik Basu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2336.
https://doi.org/10.1182/blood-2025-2336
Published: 2025
Journal Articles

Ruxolitinib for refractory immune effector cell enterocolitis following ciltacabtagene autoleucel CAR T-cell therapy for multiple myeloma

Free
Viktoria Blumenberg, Filippo Birocchi, Angela Shih, Giulia Escobar, Adele Mucci, Alexander Armstrong, Diana Cirstea, Deshea L Harris, David Bozym, Benjamin Puliafito, Richard Newcomb, Tejaswini Dhawale, Patrick Connor Johnson, Areej El-Jawahri, Richard Jeffrey, Alexis Barselau, Alex Li, Estelle Emmanuel-Alejandro, Daniella Cook, Kevin Lindell, Samantha Luk, Ryan Chaffee, Andrew Yee, Andrew Branagan, Noopur Raje, Charlotte Graham, Sarah Hammond, Frederic Bushman, Aoife Doto, Shanyan Reddy, Alexander McFarland, Yi-Bin Chen, Christopher Mount, Michael Dougan, Valentina Nardi, Aliyah Sohani, Kathleen ME Gallagher, Marcela Maus, Matthew Frigault, Mark Leick
Journal: Blood
Blood (2025) 146 (Supplement 1): 2392.
https://doi.org/10.1182/blood-2025-2392
Published: 2025
Journal Articles

Deepening responses and MRD-conversion in a phase II fixed-duration consolidation trial of elranatamab post-idecabtagene vicleucel CAR-T cell therapy (EPIC) in relapsed or refractory multiple myeloma

Free
Benjamin Puliafito, Matthew Lei, Andrew Yee, Diana Cirstea, Andrew Branagan, Emerentia Agyemang, Cynthia Harrington, Kacthary Sanclemente, Lisette Packer, Alexandra Wright, E. Bridget Kim, Brenna McCormick, Kareem Mosaheb, Julia Lin, Nora Horick, Eric Hua, Omar Nadeem, Matthew Frigault, Jacalyn Rosenblatt, Noopur Raje
Journal: Blood
Blood (2025) 146 (Supplement 1): 5824.
https://doi.org/10.1182/blood-2025-5824
Published: 2025
Journal Articles

Validation and refinement of the new high-risk multiple myeloma (HRMM) criteria in relapsed or refractory patients treated with BCMA CAR-T.

Free
Joshua Gustine, Narsis Attar, Benjamin Puliafito, Diana Cirstea, Andrew Branagan, Marcela Maus, Matthew Frigault, Andrew Yee, Noopur Raje
Journal: Blood
Blood (2025) 146 (Supplement 1): 2243.
https://doi.org/10.1182/blood-2025-2243
Published: 2025
Journal Articles

Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: Updated results from iMMagine–1

Free
Krina Patel, Binod Dhakal, Gurbakhash Kaur, Richard Maziarz, Natalie Callander, Adam Sperling, Carolina Schinke, Andrzej Jakubowiak, Noa Biran, Douglas Sborov, Cindy Varga, Larry Anderson, Abhinav Deol, Abraham Kanate, Mehmet Kocoglu, Melhem Solh, Kamalika Banerjee, Krishna Rana, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher Heery, Ciara Louise Freeman, Tim Welliver, Matthew Frigault
Journal: Blood
Blood (2025) 146 (Supplement 1): 256.
https://doi.org/10.1182/blood-2025-256
Published: 2025
Journal Articles

Absolute lymphocyte count is predictive of response to salvage therapies for post-CAR T failure

Free
Hazim Ababneh, Andrea Ng, Matthew Frigault, Caron Jacobson, Chirayu Patel
Journal: Blood
Blood (2025) 146 (Supplement 1): 1928.
https://doi.org/10.1182/blood-2025-1928
Published: 2025
Journal Articles

First-in-human phase 1 trial of trimeric APRIL (TriPRIL) CAR T cells in relapsed or refractory multiple myeloma: Clinical outcomes and biological correlates of disease response and resistance

Free
Charlotte Graham, Benjamin Puliafito, Noopur Raje, Diana Cirstea, Andrew Branagan, Andrew Yee, Nora Horick, Daniella Cook, Kevin Lindell, Danielle Bernier, Alexis Barselau, Gabrielle Furman, Meaghan Ekstrom, Jaclyn Emmett, Maxx King, Md Raihan Chowdhury, Valentina Supper, Hannah Donner, Mark Leick, Viktoria Blumenberg, Aiyana Parker, Deshea L Harris, Won-Ho Lee, Kiana Graham, Hadley Wiggin, Pascal Schneider, Jerome Ritz, Sarah Nikiforow, Heather Daley, Myriam Armant, Lu Huang, Kathleen ME Gallagher, Matthew Frigault, Marcela Maus
Journal: Blood
Blood (2025) 146 (Supplement 1): 270.
https://doi.org/10.1182/blood-2025-270
Published: 2025
Journal Articles

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma

Free
Leon D. Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, Jeremy Abramson, Jacob Soumerai, Maria Martinez-Lage, Julie Haydu, Ganesh Shankar, Chirayu Patel, Bryan D. Choi, Jeffrey Barnes, Areej El-Jawahri, Ephraim Hochberg, Patrick Connor Johnson, Wolfgang Wick, Marcela Maus, Yi-Bin Chen, Matthew Frigault, Jorg Dietrich
Journal: Blood
Blood (2025) 146 (Supplement 1): 5493.
https://doi.org/10.1182/blood-2025-5493
Published: 2025
Journal Articles

The efficacy of cilta-cel after a prior BCMA-directed CAR T-cell therapy in relapsed/refractory multiple myeloma

Free
Narsis Attar, Rajib Shome, Mehmet Samur, Joshua Gustine, Charlotte Graham, Kathleen ME Gallagher, Agustin Busse, Deshea L Harris, Diana Cirstea, Andrew Yee, Andrew Branagan, Marcela Maus, Matthew Frigault, Nikhil Munshi, Adam Sperling, Noopur Raje
Journal: Blood
Blood (2025) 146 (Supplement 1): 5764.
https://doi.org/10.1182/blood-2025-5764
Published: 2025
Journal Articles

Risk score and survival outcomes for multiple myeloma patients with disease refractory to BCMA CAR-T.

Free
Joshua Gustine, Narsis Attar, Benjamin Puliafito, Diana Cirstea, Andrew Branagan, Marcela Maus, Matthew Frigault, Andrew Yee, Noopur Raje
Journal: Blood
Blood (2025) 146 (Supplement 1): 5792.
https://doi.org/10.1182/blood-2025-5792
Published: 2025
Journal Articles

The relationship of social support and psychosocial complexity with chimeric antigen receptor T-cell therapy outcomes

Free
Jessica Nino De Rivera, Shruthi Venkatachalam, Kyle Karpinski, Elane Kim, Anna Barata, Meaghan Ekstrom, Richard Newcomb, Trisha Rahman, Nova Hodge, Lauren DeMarco, Matthew Frigault, Areej El-Jawahri, Patrick Connor Johnson
Journal: Blood
Blood (2025) 146 (Supplement 1): 4544.
https://doi.org/10.1182/blood-2025-4544
Published: 2025
Journal Articles

Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Efficacy and Safety with 34-Month Median Follow-up

Free
Michael R Bishop, Jacalyn Rosenblatt, Binod Dhakal, Noopur Raje, Daniella Cook, Mahmoud R. Gaballa, Estelle Emmanuel-Alejandro, Danielle Nissen, Kamalika Banerjee, Rebecca J Chan, Ana Kostic, Christopher R. Heery, Tim Welliver, David Avigan, Andrzej J Jakubowiak, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 4825.
https://doi.org/10.1182/blood-2024-201080
Published: 2024
Journal Articles

Biological Correlatives of Efficacy and Toxicity of BCMA Targeting CAR T Cell Therapy in a Real-World Setting

Free
Charlotte Graham, Aiyana Parker, Xiaomeng Sun, Nicholas J. Haradhvala, Maria Dolaher, Kevin Lindell, Deshea Harris, Won-Ho Lee, Kiana J Graham, Hannah K Nolan, Viktoria Blumenberg, David J Bozym, Alex Li, Hana Cho, Estelle Emmanuel-Alejandro, Arienne R Annati, Julianne Marie Gildea, Alexis Barselau, Diana Cirstea, Andrew R. Branagan, Andrew J. Yee, Noopur Raje, Gad Getz, Mark B Leick, Matthew Frigault, Kathleen Gallagher, Marcela V Maus
Journal: Blood
Blood (2024) 144 (Supplement 1): 7126.
https://doi.org/10.1182/blood-2024-194895
Published: 2024
Journal Articles

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) and Secondary Central Nervous System (sCNS) Involvement from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Free
Sairah Ahmed, Avyakta Kallam, Matthew Frigault, Bradley D. Hunter, Sagar S. Patel, David Bernasconi, Soyoung Kim, Tracy Krimmel, Fei Fei Liu, Debasmita Roy, Marcelo C. Pasquini, Jennifer L. Crombie
Journal: Blood
Blood (2024) 144 (Supplement 1): 472.
https://doi.org/10.1182/blood-2024-199702
Published: 2024
Journal Articles

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) As Second-Line (2L) Therapy in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): First Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Free
Maria Silvina Odstrcil Bobillo, Swetha Kambhampati, Dasom Lee, Bradley D. Hunter, Ogechukwu Egini, Krish Patel, Patrick M. Reagan, David Bernasconi, Soyoung Kim, Charimar Santiago Parrilla, Tracy Krimmel, Fei Fei Liu, Debasmita Roy, Sairah Ahmed, Jennifer L. Crombie, Saurabh Dahiya, Mehdi Hamadani, Catherine J. Lee, Marcelo C. Pasquini, Mazyar Shadman, Alex F. Herrera, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 470.
https://doi.org/10.1182/blood-2024-199723
Published: 2024
Journal Articles

Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial

Free
Ciara Louise Freeman, Binod Dhakal, Gurbakhash Kaur, Richard T. Maziarz, Natalie Callander, Adam S. Sperling, Carolina Schinke, Andrzej J Jakubowiak, Noa Biran, Douglas W Sborov, Cindy Varga, Abhinav Deol, Abraham S. Kanate, Mehmet Hakan Koçoğlu, Melhem M. Solh, Kamalika Banerjee, Rebecca Chan, Myrna Nahas, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher R. Heery, Tim Welliver, Krina K. Patel, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 1031.
https://doi.org/10.1182/blood-2024-198499
Published: 2024
Journal Articles

Outcomes of Salvage Radiotherapy in Relapsed/Refractory Large B-Cell Lymphoma Patients Following CAR T-Cell Therapy Failure: A Multicenter Pooled Analysis

Free
Hazim Ababneh, Andrea Ng, Andrzej Niemierko, Matthew Frigault, Caron A. Jacobson, Chirayu Patel
Journal: Blood
Blood (2024) 144 (Supplement 1): 5112.
https://doi.org/10.1182/blood-2024-202163
Published: 2024